Global Erythropoietin Stimulating Agents Market Share

Statistics for the 2023 & 2024 Global Erythropoietin Stimulating Agents market share, created by Mordor Intelligence™ Industry Reports. Global Erythropoietin Stimulating Agents share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of Global Erythropoietin Stimulating Agents Industry

The ESAs market is highly competitive, and it includes global and local companies. Some of the key players in the market are Amgen, Thermo Fisher Scientific, Johnson and Johnson, F. Hoffmann La Roche, and Pfizer Inc. Numerous pharmaceutical manufacturers are taking initiatives to develop and produce ESAs after the expiration of patents and are evolving various strategic alliances, such as acquisitions and collaborations, to expand the product portfolio globally.

Erythropoietin Stimulating Agents Market Leaders

  1. Amgen Inc.

  2. F. Hoffmann La Roche Ltd

  3. Thermo Fisher Scientific

  4. Johnson and Johnson

  5. Pfizer Inc.

*Disclaimer: Major Players sorted in no particular order

Amgen, Thermo Fisher Scientific, Johnson and Johnson, F. Hoffmann La Roche, and Pfizer Inc

Erythropoietin Stimulating Agents Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)